---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-037533"
form_type: "8-K"
ticker: "LFST"
cik: "0001845257"
company_name: "LifeStance Health Group, Inc."
filed_at: "2025-02-27T23:59:59+00:00"
generated_at: "2026-05-26T02:29:35.871896+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# LifeStance appoints Dave Bourdon as CEO; Ken Burdick becomes Executive Chairman; Ryan McGroarty named CFO

## Summary
- Dave Bourdon, CFO since 2022, becomes CEO effective March 3, 2025; Ryan McGroarty appointed CFO effective March 17, 2025.
- Ken Burdick retires as CEO and becomes Executive Chairman, continuing on the Board.
- Bourdon's new annual base salary is $700,000; target bonus 100% of salary for 2025.
- McGroarty receives $550,000 base salary, $570,000 signing bonus, and $5M target equity award (RSUs and PSUs).
- Both appointments follow nine consecutive quarters of meeting or exceeding financial expectations.

## SEC filing metadata
- accession: 0001193125-25-037533
- form_type: 8-K
- ticker: LFST
- cik: 0001845257
- company_name: LifeStance Health Group, Inc.
- filed_at: 2025-02-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1845257/000119312525037533/0001193125-25-037533-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1845257/000119312525037533/d911509d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-037533
- JSON: https://secwatch.observer/filing/0001193125-25-037533.json
- Plain text: https://secwatch.observer/filing/0001193125-25-037533.txt

## Key facts
- Executive change
  Kenneth Burdick retired as Executive Chairman at LifeStance Health Group, Inc..
  - Action: retired
  - Role: Executive Chairman
  source text: Mr. Bourdon will succeed Kenneth Burdick, who has served as the Company’s Chief Executive Officer since 2022 and who is retiring from his position, effective as of the CEO Start Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1845257/000119312525037533/0001193125-25-037533-index.htm
- Executive change
  David Bourdon changed role as Chief Executive Officer at LifeStance Health Group, Inc..
  - Action: promoted
  - Role: Chief Executive Officer
  source text: promoted David Bourdon to serve as the Company’s Chief Executive Officer effective as of March 3, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/1845257/000119312525037533/0001193125-25-037533-index.htm
- Executive change
  Ryan McGroarty was appointed as Chief Financial Officer and Treasurer at LifeStance Health Group, Inc..
  - Action: appointed
  - Role: Chief Financial Officer and Treasurer
  source text: the Board of Directors also appointed Ryan McGroarty as the Company’s Chief Financial Officer and Treasurer, effective as of March 17, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/1845257/000119312525037533/0001193125-25-037533-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.